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Background:  Low-density lipoprotein cholesterol (LDL-C) lowering is a primary target for secondary prevention after acute myocardial infarction 
(AMI). Identifying modifiable factors associated with failure to achieve lipid goals can help improve post-AMI care.
Methods:  In the TRIUMPH study, we examined the subset of 366 patients with LDL-C ≥100 mg/dl at baseline and a 6-month fasting LDL-C 
reassessment. Among 63 patient and provider factors assessed in univariate analyses, 11 factors were examined in hierarchical modified Poisson 
regression for their independent association with failure to achieve the guidelines LDL-C goal of <100 mg/dl at 6 months.
Results:  LDL-C remained ≥100 mg/dl in 121 patients (33%) at 6 months with a median of 125 mg/dl. Compared with patients reaching 
goal, those above goal were less often discharged on a statin (79 vs. 91%, p<0.001; despite only 4% having contraindications), and were more 
likely to discontinue use by 6 months (24 vs. 6%, p<0.001). In multivariable analysis, provider failure to prescribe a statin at discharge, patient 
discontinuation of statin therapy by 6 months, non-white race and lack of insurance were independently associated with lack of LDL-C goal 
attainment (Figure).
Conclusion: One-third of AMI patients do not attain a LDL-C <100 mg/dl at 6 months. Targeted interventions aimed at the transition of AMI care to 
emphasize affordable statin prescriptions and medication persistence may promote more effective lipid lowering and improve patient outcomes.
